Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12608000058370
ACTRN12608000058370
Completed
Not Applicable

For patients undergoing Computed Tomography (CT) Enteroclysis, self administered methoxyflurane via the Penthrox® inhaler may be better than placebo at improving patient tolerance of the procedure

Dr Alan Moss, Principal Investigator, Penthrox for CTE trial0 sites60 target enrollmentJanuary 30, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCT enteroclysis toleranceOral and Gastrointestinal - Inflammatory bowel disease

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
CT enteroclysis tolerance
Sponsor
Dr Alan Moss, Principal Investigator, Penthrox for CTE trial
Enrollment
60
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 30, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Alan Moss, Principal Investigator, Penthrox for CTE trial

Eligibility Criteria

Inclusion Criteria

  • •Referred for CT enteroclysis
  • •Age 16 years or older
  • •Able to give written informed consent themselves

Exclusion Criteria

  • •Known pre\-existing renal or hepatic impairment: serum creatinine \= 1\.5 x upper limit of normal range (ULNR) or bilirubin \= 2 x upper limit of normal range (ULNR).
  • •Concomitant use of any of the following medications: tetracyclines, gentamicin, kanamycin, colistin, polymyxin b, cephaloridine or amphotericin b.
  • •Personal or familial hypersensitivity to fluorinated anaesthetics.
  • •Personal or familial malignant hyperthermia.
  • •Pre\-medication with anxiolytic eg. midazolam, diazepam.
  • •Pre\-medication with breakthrough dose of analgesic eg. paracetamol plus codeine or oxycodone.
  • •Hypotension pre\-procedure: systolic blood pressure \<90 mmHg.
  • •Bradycardia pre\-procedure: heart rate \<50 bpm.
  • •Poor oxygen saturation pre\-procedure: O2 saturation \<90%.
  • •Pregnancy: currently pregnant or attempting to become pregnant.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Computed Tomography (CT) imaging evaluation of integrated Traditional Chinese Medicine cooperative therapy in treating Acute Cerebral Infarction: a randomized controlled trial
ITMCTR2000003053Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Completed
Not Applicable
Clinical Validation of Computed Tomography derived Myocardial Perfusion Imaging : a Hybrid PET/CT Study (ContRaSt)coronary artery diseasemyocardial perfusion10011082
NL-OMON51073niversitair Medisch Centrum10
Recruiting
Not Applicable
Clinical Validation of Computed Tomography derived Myocardial Perfusion Imaging: a Hybrid PET-CT Pilot Study II (ContRaSt II)coronary artery diseasemyocardial perfusion10011082
NL-OMON51326niversitair Medisch Centrum Groningen20
Completed
Not Applicable
Therapeutic evaluation of Computed Tomography findings for efficacy of prone ventilation in Acute Respiratory Distress Syndrome patients with abdominal surgeryARDS
JPRN-UMIN000034851Sapporo Medical University School of Medicine60
Completed
Not Applicable
Computed tomography (CT)-guided intervention with and without fluoroscopic control: what are the benefits for the patient and the doctor?
ISRCTN23480116Department of Health50